Qualifying Therapeutic Discovery Project Grants for the State of Kentucky
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| Advanced Genomic Technology, LLC | Circulating RNA diagnostic for metastatic ovarian carcinoma:an animal model study | $ 244,479.25 | |
| ALLTranz Inc | Abuse Deterrent Transdermal Buprenorphine for Treatment of Pain and Opiate Addiction | $ 79,584.13 | $ 68,561.57 |
| ALLTRANZ Inc | Transdermal Cannabinoid Prodrug Treatment | $ 90,303.08 | $ 154,176.16 |
| Alltranz Inc | Transdermal Cannabidiol for Treatment of Osteoarthritis, Alcoholism, And Other Diseases | $ 114,288.70 | $ 85,744.68 |
| ALT BioScience LLC | Periodonatl diagnostic strip | $ 244,479.25 | |
| Apellis Pharmaceuticals, Inc. | Complement Inhibitors as a Therapeutic for Asthma | $ 244,479.25 | |
| ApoImmue, Inc | ApoVax104 as a Novel Vaccine Platform Technology | $ 244,479.25 | |
| Assenti LLC | IOP and Therapeutic Monitoring System for Glaucoma Patients | $ 54,310.50 | |
| CeeLA Naturals | Burn Treatment Adjuvant Therapies | $ 60,503.50 | $ 114,405.00 |
| CTI Science Inc | NBMI Drug Approval | $ 230,691.00 | $ 13,788.24 |
| EndoProtech, Inc. | Novel Therapy to improve outcomes in cardiac transplantation | $ 166,515.50 | $ 77,963.74 |
| Kentucky Pharmacecuticals Inc | Inflammation-Targeting theragnostic nanocomposite system for the eye | $ 244,479.25 | |
| NeoCytex Biopharma Inc. | Novel Neuroregenerative Drug Therapy for Stroke | $ 115,894.93 | $ 38,209.84 |
| OrthoData, Inc | Diagnostic improvements in spinal fusion | $ 244,479.25 | |
| Potentia Pharmaceuticals, Inc | POT-4 | $ 244,479.25 | |
| Pradama, Inc. | Bone-targeted Vancomycin for the Treatment of Osteomyelitis (Bone Infection) | $ 43,771.50 | $ 133,681.00 |
| Re-Borne Inc | Re-Borne Prosperity Project | $ 73,500.00 | |
| Regenerex. LLC | FCRx for Safe Bone Marrow Transplantation | $ 167,516.00 | $ 76,963.25 |
| RhinoCyte, Inc. | The use of olfactory of stem cells for neurodegeneration | $ 244,479.24 | |
| Summit Biosciences Inc. | THC-nasal spray | $ 138,247.00 | |
| Summit Biosciences LLC | THC- nasal spray | $ 9,639.00 | |
| Vindico NanoBio Technology, Inc. | Polymersomes, a nonoparticle-based delivery platform | $ 40,291.27 | $ 188,204.85 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-12
